In a bid to prevent new infections of HIV among most-at-risk populations such as sex workers in Nigeria, the country was selected to play host to a pre-exposure prophylaxis (PrEP) demonstration project among serodiscordant couples in select states. The project which is scheduled to run from late-2015 until late-2017 is currently ongoing but there have been challenges in accessing PrEP by many sex workers.
According to the Center for Disease Prevention and Control (CDC), PrEP is when people at very high risk for HIV take HIV medicines daily to lower their chances of getting infected. Oral PrEP contains the antiretroviral drugs tenofovir and emtricitabine and studies show that it can drastically reduce the risk of infection if used properly. The drug is taken prior sex with an HIV-infected person or to ensure safety during sex without condom even if the other partner is not living with HIV.




